Skip to main content
. Author manuscript; available in PMC: 2021 Jan 26.
Published in final edited form as: Am J Med Genet A. 2018 Jan 24;176(3):649–656. doi: 10.1002/ajmg.a.38600

FIGURE 4.

FIGURE 4

Altered levels of VEGFR2 phosphorylation from patient amniocytes (A), endothelial cells (EC) and co-cultured amniocytes and endothelial cells (EC+A). Ratio of phosphorylated (p) VEGFR2 at tyrosine 1175 versus total VEGFR2 were altered in endothelial cell (EC) when co-cultured with patient cells (3.4-fold) compared to endothelial cells co-cultured with control cells (1.3). SMA is an amniocyte marker.